IRONWOOD PHARMACEUTICALS, INC. Earnings Per Share, Basic and Diluted
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Earnings Per Share, Basic and Diluted of $0.16 per share for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2020-08-06
- IRONWOOD PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2020-06-30 was $0.16, a 100.00% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2020-03-31 was $0.02.
- IRONWOOD PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2019-09-30 was $0.13.
- IRONWOOD PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2019-06-30 was $0.08.
- IRONWOOD PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2019 was $0.14.
- IRONWOOD PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2018 was -$1.85.
- IRONWOOD PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2017 was -$0.78.
- IRONWOOD PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2016 was -$0.56.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-06-30 | $0.16 10-Q · filed 2020-08-06 | $0.18 10-Q · filed 2020-08-06 | ||
| 2020-03-31 | $0.02 10-Q · filed 2020-05-06 | |||
| 2019-12-31 | $0.14 10-K · filed 2020-02-13 | |||
| 2019-09-30 | $0.13 10-Q · filed 2019-10-31 | -$0.17 10-Q · filed 2019-10-31 | ||
| 2019-06-30 | $0.08 10-Q · filed 2020-08-06 | -$0.30 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | -$0.38 10-Q · filed 2020-05-06 | |||
| 2018-12-31 | -$0.10 10-K · filed 2020-02-13 | -$1.85 10-K · filed 2020-02-13 | ||
| 2018-09-30 | -$1.14 10-K · filed 2020-02-13 | -$1.75 10-Q · filed 2019-10-31 | ||
| 2018-06-30 | -$0.32 10-K · filed 2020-02-13 | -$0.61 10-Q · filed 2019-07-30 | ||
| 2018-03-31 | -$0.29 10-K · filed 2020-02-13 | |||
| 2017-12-31 | $0.08 10-K · filed 2019-02-25 | -$0.78 10-K · filed 2020-02-13 | ||
| 2017-09-30 | -$0.22 10-K · filed 2019-02-25 | -$0.87 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | -$0.30 10-K · filed 2019-02-25 | -$0.65 10-Q · filed 2018-08-06 | ||
| 2017-03-31 | -$0.36 10-K · filed 2019-02-25 | -$0.23 derived: net income ÷ weighted average shares · filed 2019-02-25 | -$0.51 derived: net income ÷ weighted average shares · filed 2019-02-25 | -$0.83 derived: net income ÷ weighted average shares · filed 2019-02-25 |
| 2016-12-31 | -$0.09 10-K · filed 2018-02-22 | -$0.16 derived: net income ÷ weighted average shares · filed 2019-02-25 | -$0.35 derived: net income ÷ weighted average shares · filed 2019-02-25 | -$0.56 10-K · filed 2019-02-25 |
| 2016-09-30 | -$0.23 10-K · filed 2018-02-22 | -$378.89 derived: net income ÷ weighted average shares · filed 2017-11-02 | -$0.47 10-Q · filed 2017-11-02 | -$0.58 derived: net income ÷ weighted average shares · filed 2018-02-22 |
| 2016-06-30 | -$0.15 10-K · filed 2018-02-22 | -$0.24 10-Q · filed 2017-08-03 | -$0.26 derived: net income ÷ weighted average shares · filed 2018-02-22 | -$0.68 derived: net income ÷ weighted average shares · filed 2018-02-22 |
| 2016-03-31 | -$0.09 10-K · filed 2018-02-22 | -$0.10 derived: net income ÷ weighted average shares · filed 2018-02-22 | -$0.39 derived: net income ÷ weighted average shares · filed 2018-02-22 | -$0.69 derived: net income ÷ weighted average shares · filed 2018-02-22 |
| 2015-12-31 | -$0.09 10-K · filed 2017-02-22 | -$0.22 derived: net income ÷ weighted average shares · filed 2018-02-22 | -$0.46 derived: net income ÷ weighted average shares · filed 2018-02-22 | -$1.00 10-K · filed 2018-02-22 |
| 2015-09-30 | -$0.33 10-K · filed 2017-02-22 | -$1.34 derived: net income ÷ weighted average shares · filed 2017-02-22 | -$0.91 10-Q · filed 2016-11-07 | -$1.57 derived: net income ÷ weighted average shares · filed 2017-02-22 |
| 2015-06-30 | -$0.34 10-K · filed 2017-02-22 | -$0.57 10-Q · filed 2016-08-08 | -$0.84 derived: net income ÷ weighted average shares · filed 2017-02-22 | -$1.14 derived: net income ÷ weighted average shares · filed 2017-02-22 |
| 2015-03-31 | -$0.24 10-K · filed 2017-02-22 | -$0.50 derived: net income ÷ weighted average shares · filed 2017-02-22 | -$0.81 derived: net income ÷ weighted average shares · filed 2017-02-22 | -$1.24 derived: net income ÷ weighted average shares · filed 2017-02-22 |
| 2014-12-31 | -$0.27 10-K · filed 2016-02-19 | -$0.57 derived: net income ÷ weighted average shares · filed 2017-02-22 | -$1.01 derived: net income ÷ weighted average shares · filed 2017-02-22 | -$1.39 10-K · filed 2017-02-22 |
| 2014-09-30 | -$0.30 10-K · filed 2016-02-19 | -$0.74 derived: net income ÷ weighted average shares · filed 2016-02-19 | -$1.12 10-Q · filed 2015-11-05 | -$0.94 derived: net income ÷ weighted average shares · filed 2016-02-19 |
| 2014-06-30 | -$0.44 10-K · filed 2016-02-19 | -$0.82 10-Q · filed 2015-08-07 | -$0.66 derived: net income ÷ weighted average shares · filed 2016-02-19 | -$1.22 derived: net income ÷ weighted average shares · filed 2016-02-19 |
| 2014-03-31 | -$0.38 10-K · filed 2016-02-19 | -$0.34 derived: net income ÷ weighted average shares · filed 2016-02-19 | -$0.83 derived: net income ÷ weighted average shares · filed 2016-02-19 | -$1.29 derived: net income ÷ weighted average shares · filed 2016-02-19 |
| 2013-12-31 | -$0.43 10-K · filed 2015-02-18 | -$0.49 derived: net income ÷ weighted average shares · filed 2016-02-19 | -$0.93 derived: net income ÷ weighted average shares · filed 2016-02-19 | -$2.35 10-K · filed 2016-02-19 |
| 2013-09-30 | -$0.51 10-K · filed 2015-02-18 | -$2.24 derived: net income ÷ weighted average shares · filed 2015-02-18 | -$1.93 10-Q · filed 2014-11-05 | |
| 2013-06-30 | -$0.57 10-K · filed 2015-02-18 | -$1.44 10-Q · filed 2014-08-05 | ||
| 2013-03-31 | -$0.87 10-K · filed 2015-02-18 | |||
| 2012-12-31 | -$0.68 10-K · filed 2015-02-18 | |||
| 2012-06-30 | -$0.38 10-Q · filed 2013-08-08 | -$0.73 10-Q · filed 2013-08-08 | ||
| 2012-03-31 | -$0.34 10-Q · filed 2013-04-23 | |||
| 2011-12-31 | -$0.07 10-K · filed 2012-02-29 | -$0.65 10-K · filed 2014-02-07 | ||
| 2011-09-30 | -$0.21 10-K · filed 2012-02-29 | -$0.58 10-Q · filed 2011-11-09 | ||
| 2011-06-30 | -$0.19 10-Q · filed 2012-08-07 | -$0.37 10-Q · filed 2012-08-07 | ||
| 2011-03-31 | -$0.19 10-Q · filed 2012-05-10 | |||
| 2010-12-31 | -$0.12 10-K · filed 2012-02-29 | -$0.59 10-K · filed 2013-02-21 | ||
| 2010-09-30 | -$0.08 10-K · filed 2012-02-29 | -$0.48 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | -$0.18 10-K · filed 2012-02-29 | |||
| 2010-03-31 | -$0.25 10-K · filed 2012-02-29 | |||
| 2009-12-31 | -$10.00 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |